---
title: 'Publications'
date: 2022-24-01
menu:
  main:
    weight: 5
    name: "Publications"
  footer_secondary:
    name: "Publications"
    weight: 5
description: "Our publication track record"
image: "images/gen/content/content-6-thumbnail.webp"
---

# 2022

1. An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection.
Sanchez-Burgos L, Gómez-López G, Al-Shahrour F, Fernandez-Capetillo O. Sci Rep. 2022 Jan 31;12(1):1626. doi: 10.1038/s41598-022-05597-x. PMID: 35102208; PMCID: PMC8803893.

1. Bioinformatics roadmap for therapy selection in cancer genomics.
Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F.  Mol Oncol. 2022 Nov;16(21):3881-3908. doi: 10.1002/1878-0261.13286. Epub 2022 Aug 20. PMID: 35811332; PMCID: PMC9627786.

1. Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Rogado J, Pozo F, Troulé K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R. Clin Transl Oncol. 2022 Nov;24(11):2241-2249. doi: 10.1007/s12094-022-02887-8. Epub 2022 Jul 23. PMID: 35870091.

1. Origins and evolution of human tandem duplicated exon substitution events.
Martinez-Gomez L, Cerdán-Vélez D, Abascal F, Tress ML. Genome Biol Evol. 2022 Nov 8:evac162. doi: 10.1093/gbe/evac162. Epub ahead of print. PMID: 36346145.

1. Clinical variant interpretation and biologically relevant reference transcripts.
Pozo F, Rodriguez JM, Vázquez J, Tress ML. NPJ Genom Med. 2022 Oct 18;7(1):59. doi: 10.1038/s41525-022-00329-6. PMID: 36257961; PMCID: PMC9579139.

1. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.
Kayumi S, Pérez-Jurado LA, Palomares M, Rangu S, Sheppard SE, Chung WK, Kruer MC, Kharbanda M, Amor DJ, McGillivray G, Cohen JS, García-Miñaúr S, van Eyk CL, Harper K, Jolly LA, Webber DL, Barnett CP, Santos-Simarro F, Pacio-Míguez M, Pozo AD, Bakhtiari S, Deardorff M, Dubbs HA, Izumi K, Grand K, Gray C, Mark PR, Bhoj EJ, Li D, Ortiz-Gonzalez XR, Keena B, Zackai EH, Goldberg EM, Perez de Nanclares G, Pereda A, Llano-Rivas I, Arroyo I, Fernández-Cuesta MÁ, Thauvin-Robinet C, Faivre L, Garde A, Mazel B, Bruel AL, Tress ML, Brilstra E, Fine AS, Crompton KE, Stegmann APA, Sinnema M, Stevens SCJ, Nicolai J, Lesca G, Lion-François L, Haye D, Chatron N, Piton A, Nizon M, Cogne B, Srivastava S, Bassetti J, Muss C, Gripp KW, Procopio RA, Millan F, Morrow MM, Assaf M, Moreno-De-Luca A, Joss S, Hamilton MJ, Bertoli M, Foulds N, McKee S, MacLennan AH, Gecz J, Corbett MA.  Genet Med. 2022 Nov;24(11):2351-2366. doi: 10.1016/j.gim.2022.08.006. Epub 2022 Sep 9. PMID: 36083290.

1. Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.
Barradas M, Plaza A, Colmenarejo G, Lázaro I, Costa-Machado LF, Martín-Hernández R, Micó V, López-Aceituno JL, Herranz J, Pantoja C, Tejero H, Diaz-Ruiz A, Al-Shahrour F, Daimiel L, Loria-Kohen V, Ramirez de Molina A, Efeyan A, Serrano M, Pozo OJ, Sala-Vila A, Fernandez-Marcos PJ. Nat Commun. 2022 Sep 27;13(1):5677. doi: 10.1038/s41467-022-33352-3. PMID: 36167809; PMCID: PMC9515185.

1. APPRIS principal isoforms and MANE Select transcripts define reference splice variants. 
Pozo F, Rodriguez JM, Martínez Gómez L, Vázquez J, Tress ML. Bioinformatics. 2022 Sep 16;38(Supplement_2):ii89-ii94. doi: 10.1093/bioinformatics/btac473. PMID: 36124785; PMCID: PMC9486585.

1. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
Jutzi JS, Marneth AE, Ciboddo M, Guerra-Moreno A, Jiménez-Santos MJ, Kosmidou A, Dressman JW, Liang H, Hamel R, Lozano P, Rumi E, Doench JG, Gotlib J, Krishnan A, Elf S, Al-Shahrour F, Mullally A. Blood. 2022 Sep 15;140(11):1291-1304. doi: 10.1182/blood.2022015629. PMID: 35763665; PMCID: PMC9479036.

1. Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells.
Sanchez-Burgos L, Navarro-González B, García-Martín S, Sirozh O, Mota-Pino J, Fueyo-Marcos E, Tejero H, Antón ME, Murga M, Al-Shahrour F, Fernandez-Capetillo O. EMBO Mol Med. 2022 Sep 7;14(9):e15855. doi: 10.15252/emmm.202215855. Epub 2022 Jul 21. PMID: 35861150; PMCID: PMC9449593.

1. Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers. 
Martín A, Epifano C, Vilaplana-Marti B, Hernández I, Macías RIR, Martínez-Ramírez Á, Cerezo A, Cabezas-Sainz P, Garranzo-Asensio M, Amarilla-Quintana S, Gómez-Domínguez D, Caleiras E, Camps J, Gómez-López G, Gómez de Cedrón M, Ramírez de Molina A, Barderas R, Sánchez L, Velasco-Miguel S, Pérez de Castro I. Cell Death Differ. 2022 Jul 22. doi: 10.1038/s41418-022-01044-6. Epub ahead of print. PMID: 35869285.

1. Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Rogado J, Pozo F, Troule K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R. Cancers (Basel). 2022 Jun 12;14(12):2898. doi: 10.3390/cancers14122898. PMID: 35740564; PMCID: PMC9221141.

1. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice
Kovtonyuk LV, Caiado F, Garcia-Martin S, Manz EM, Helbling P, Takizawa H, Boettcher S, Al-Shahrour F, Nombela-Arrieta C, Slack E, Manz MG. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood. 2022 Jan 6;139(1):44-58. doi: 10.1182/blood.2021011570. PMID: 34525198.

1. Endothelial Cell RNA-Seq Data: Differential Expression and Functional Enrichment Analyses to Study Phenotypic Switching. 
Pinel GD, Horder JL, King JR, McIntyre A, Mongan NP, López GG, Benest AV.  
Methods Mol Biol. 2022;2441:369-426. doi: 10.1007/978-1-0716-2059-5_29. PMID: 35099752.
